Log in

NASDAQ:AGLEAeglea Bio Therapeutics Insider Trades

$5.21
+0.36 (+7.42 %)
(As of 04/9/2020 01:09 AM ET)
Add
Compare
Today's Range
$4.95
Now: $5.21
$5.43
50-Day Range
$3.51
MA: $5.67
$8.22
52-Week Range
$3.50
Now: $5.21
$9.10
Volume98,300 shs
Average Volume64,786 shs
Market Capitalization$151.53 million
P/E RatioN/A
Dividend YieldN/A
Beta1.38

Insider Trades

Aeglea Bio Therapeutics (NASDAQ:AGLE) Insider Buying and Selling Activity

Insider Ownership Percentage: 12.60%

Insider Buying and Selling by Quarter

Aeglea Bio Therapeutics (NASDAQ AGLE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2019Anthony G QuinnCEOBuy31,905$6.16$196,534.80333,955  
6/12/2019Anthony G QuinnCEOBuy12,217$6.11$74,645.87333,955  
5/22/2019Anthony G QuinnCEOBuy26,592$6.77$180,027.84304,135  
5/20/2019Anthony G QuinnCEOBuy8,989$6.56$58,967.84304,135  
5/17/2019Anthony G QuinnCEOBuy6,218$6.65$41,349.70277,152  
5/15/2019Anthony G QuinnCEOBuy6,256$6.76$42,290.56277,152  
2/15/2019Anthony G QuinnCEOBuy719$7.10$5,104.90277,152  
9/27/2018Aaron SchuchartInsiderSell6,000$9.50$57,000.008,400  
5/10/2018Bioventures Ltd NovartisMajor ShareholderSell73,955$10.12$748,424.60  
5/7/2018Bioventures Ltd NovartisMajor ShareholderSell15,548$10.11$157,190.28  
12/8/2017Anthony G QuinnCEOBuy8,288$4.96$41,108.4832,009  
12/6/2017Anthony G QuinnCEOBuy4,888$4.92$24,048.9632,009  
12/5/2017Charles N York IICFOBuy25,959$4.48$116,296.3210,828  
12/4/2017Anthony G QuinnDirectorBuy7,956$4.98$39,620.8814,100  
12/1/2017Anthony G QuinnDirectorBuy4,100$4.53$18,573.0014,100  
12/1/2017Charles N York IICFOBuy6,500$4.59$29,835.0010,828  
2/21/2017Orbimed Advisors LlcMajor ShareholderBuy109,300$5.16$563,988.00  
4/12/2016Anthony QuinnDirectorBuy10,000$10.00$100,000.0010,000  
4/12/2016Bioventures Ltd NovartisMajor ShareholderBuy300,000$10.00$3,000,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel